Taisho Pharmaceutical R & D is categorized under Biological Research in Morristown, NJ and active since 2011.
Taisho Pharmaceutical R & D was established in 2011, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a Biological Research business, which does work in the B2B market, and is classified as a Biological Research, under code number 4242101 by the NAICS.
If you are seeking more information, feel free to contact Shigeru Nakayama, President at the company’s single location by writing to 350 Mount Kemble Avenue # 3, Morristown, New Jersey NJ 07960 or by phoning (973) 285-0870. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Taisho Pharmaceutical R & D |
| Contact Person: | Shigeru Nakayama, President |
| Address: | 350 Mount Kemble Avenue # 3, Morristown, New Jersey 07960 |
| Phone Number: | (973) 285-0870 |
| Annual Revenue (USD): | $20.000.000 to $49.9999.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biological Research |
| SIC Code: | 8731 |
| NAICS Code: | 4242101 |
| Share This Business: |
Taisho Pharmaceutical R & D was started in 2011 to provide professional Biological Research under the SIC code 8731 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.
Feel free to contact Shigeru Nakayama, President for inquiries that concern Taisho Pharmaceutical R & D by calling the company number (973) 285-0870, as your correspondence is most welcome. Additionally, the physical location of the single location of Taisho Pharmaceutical R & D can be found at the coordinates 40.775055,-74.502476 as well as the street address 350 Mount Kemble Avenue # 3 in Morristown, New Jersey 07960.
For its online presence, you may visit Taisho Pharmaceutical R & D’s website at and engage with its social media outlets through on Twitter and on Facebook.